17 trials changed in the last 30 days: 1 stopped, 7 with notable changes, 9 with minor changes only.
Withdrawn before enrolling
Sponsor's reason: IRB Withdrew Study Due to Study Design Change
University of ChicagoNot specified NCT07756242 Registry history of NCT07756242 on ClinicalTrials.gov (opens the registry)
Updated
Primary and study completion pushed from Oct 2026 to Dec 2027
University of ChicagoNot specified NCT07211230 Registry history of NCT07211230 on ClinicalTrials.gov (opens the registry)
Updated
Primary and study completion pushed from Dec 2026 to Dec 2027
University of ChicagoNot applicable NCT06343831 Registry history of NCT06343831 on ClinicalTrials.gov (opens the registry)
Updated
Primary endpoint(s) modified
Also in this update: Results posted: Sep 23, 2026; Trial completed
University of ChicagoPhase 2 NCT05624528 Registry history of NCT05624528 on ClinicalTrials.gov (opens the registry)
Updated
Primary endpoint(s) modified
University of ChicagoPhase 1/2 NCT06305286 Registry history of NCT06305286 on ClinicalTrials.gov (opens the registry)
Updated
Recruitment opened
University of ChicagoPhase 1/2 NCT07389239 Registry history of NCT07389239 on ClinicalTrials.gov (opens the registry)
Updated
Recruitment opened
University of ChicagoNot applicable NCT07346183 Registry history of NCT07346183 on ClinicalTrials.gov (opens the registry)
Updated
Recruitment opened
University of ChicagoNot applicable NCT07553234 Registry history of NCT07553234 on ClinicalTrials.gov (opens the registry)
Updated
Enrollment closed, study ongoing
University of ChicagoNot applicable NCT05608694 Registry history of NCT05608694 on ClinicalTrials.gov (opens the registry)
Updated
Primary completion pushed from Sep 30, 2029 to Dec 31, 2029
Also in this update: Study completion pushed from Oct 31, 2029 to Feb 27, 2030
University of ChicagoPhase 2 NCT07808333 Registry history of NCT07808333 on ClinicalTrials.gov (opens the registry)
Updated
Trial completed
University of ChicagoNot applicable NCT04225507 Registry history of NCT04225507 on ClinicalTrials.gov (opens the registry)
Updated
Trial completed
Also in this update: Study completion date changed from estimate of Sep 10, 2026 to Apr 16, 2026
University of ChicagoNot applicable NCT05337514 Registry history of NCT05337514 on ClinicalTrials.gov (opens the registry)
Updated
Enrollment reduced: 300 → 246 participants
University of ChicagoNot applicable NCT06651788 Registry history of NCT06651788 on ClinicalTrials.gov (opens the registry)
Updated
Enrollment increased: 180 → 220 participants
University of ChicagoNot applicable NCT06162897 Registry history of NCT06162897 on ClinicalTrials.gov (opens the registry)
Updated
Primary completion date changed from estimate of Oct 2029 to Apr 6, 2026
University of ChicagoPhase 1/2 NCT06349590 Registry history of NCT06349590 on ClinicalTrials.gov (opens the registry)
Updated
Registry marked status Unknown (sponsor has not verified the record since Aug 2024); last known: Recruiting
University of ChicagoNot applicable NCT06364358 Registry history of NCT06364358 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since Mar 2023); last known: Recruiting
University of ChicagoNot applicable NCT05766826 Registry history of NCT05766826 on ClinicalTrials.gov (opens the registry)
Changed
Registry verification sweep
Changed
| First posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-10-15 | NCT07875712 Risk Sharing vs Risk Dumping: Parental Attitudes About Risks | Not Yet Recruiting | |
| 2026-10-13 | NCT07871149 PMOS in OSA Pilot Study | Recruiting | |
| 2026-10-13 | NCT07871747 Microbiome Intervention for CAR-T Optimization and Response (MICRO-CART) | Phase 1 | Not Yet Recruiting |
| 2026-09-29 | NCT07847567 Building Rapid Inpatient Delivery of ART to Generate Engagement in HIV Care | Not Yet Recruiting |
| Early Phase 1 | 4 | |
| Phase 1 | 21 | |
| Phase 1/2 | 11 | |
| Phase 2 | 33 | |
| Phase 2/3 | 2 | |
| Phase 3 | 4 | |
| Phase 4 | 6 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 4 | ||||
| NCT07773155 | Pain Control With Ketorolac and Nerve Block After Wrist and Hand Surgery | Surgery, Upper Extremity | Recruiting | 2026-08-19 |
| NCT04479072 | Aspirin and Preeclampsia | Preeclampsia Postpartum | Recruiting | 2026-05-04 |
| NCT02118467 | Vasoactive Drugs in Intensive Care Unit | Shock | Recruiting | 2026-01-13 |
| NCT05512754 | Impact of Anti-inflammatory Medications in Patients With Elevated Serum Prostate-specific… | Elevated Serum PSA | Recruiting | 2025-12-09 |
| NCT06008860 | A Pilot Clinical Evaluation of Astepro® Nasal Spray for Management of Early SARS-CoV-2… | COVID-19 | Recruiting | 2025-11-10 |
| NCT06660862 | Evaluating Treatment Outcomes Using Darolutamide and Androgen Deprivation Therapy in… | Prostate Cancer | Not Yet Recruiting | 2026-01-08 |
| Phase 3 | ||||
| NCT06499857 | Semaglutide for Metabolic Intervention and Adipose Loss to Treat Atrial Fibrillation | Overweight or Obesity | Recruiting | 2025-11-14 |
| NCT06790342 | Optimizing Treatment of Co-occurring Smoking and Unhealthy Alcohol Use Among PWH in… | HIV | Not Yet Recruiting | 2026-07-30 |
| NCT02659293 | Trial of Carfilzomib, Lenalidomide, Dexamethasone Versus Lenalidomide Alone After… | Multiple Myeloma | Active, Not Recruiting | 2026-03-04 |
| NCT03729804 | Carfilzomib, Lenalidomide, and Dexamethasone Versus Bortezomib, Lenalidomide and… | Multiple Myeloma | Active, Not Recruiting | 2026-03-04 |
| Phase 2/3 | ||||
| NCT05796752 | Behavioral Treatment and Memantine in Body Focused Repetitive Behaviors | Skin-Picking | Active, Not Recruiting | 2026-07-07 |
| NCT04948203 | Assessing the Efficacy of Sirolimus in Patients With COVID-19 Pneumonia for Prevention of… | Pulmonary Fibrosis | Active, Not Recruiting | 2025-12-15 |
| Phase 2 | ||||
| NCT06635889 | Intravesical Bupivacaine on Post-Operative Ureteroscopy Pain | Nephrolithiasis | Recruiting | 2026-10-13 |
| NCT05789303 | Study of Belantamab Mafodotin With Carfilzomib, Pomalidomide, and Dexamethasone in… | Multiple Myeloma | Recruiting | 2026-09-23 |
| NCT05640271 | Tocilizumab for Acute Chest Syndrome | Sickle Cell Disease | Recruiting | 2026-09-15 |
| NCT02747303 | Frameless Stereotactic Radiosurgery for Intact Brain Metastases | Brain Metastases | Recruiting | 2026-09-14 |
| NCT04107077 | Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy… | Gastric Cancer | Recruiting | 2026-09-08 |
| NCT05726292 | A Study of Enzalutamide Plus the Glucocorticoid Receptor Antagonist Relacorilant Versus… | Prostate Cancer | Recruiting | 2026-08-31 |
| NCT07179315 | A Study Comparing Two Immunotherapy Options for Human Papillomavirus Positive… | Head and Neck Cancer | Recruiting | 2026-07-16 |
| NCT05790213 | Prostate Cancer Treatment Using Androgen Deprivation Therapy and Focal Prostate Ablation | Prostate Cancer | Recruiting | 2026-06-16 |
| NCT07603856 | A Study Evaluating The Combination of Immunotherapy With Radiotherapy in Non-Small Cell… | Non-Small Cell Lung Cancer | Recruiting | 2026-06-16 |
| NCT04747912 | Study of Chemotherapy-Free Induction Regimen for Ph+ Acute Lymphoblastic Leukemia With… | Lymphoblastic Leukemia | Recruiting | 2026-06-05 |
| NCT06191198 | Communication Bridge 3 Study | Primary Progressive Aphasia | Recruiting | 2026-06-01 |
| NCT05420948 | A Study of Pembrolizumab in Combination With Chemotherapy for Head and Neck Cancer | Head and Neck Cancer | Recruiting | 2026-05-12 |
| NCT06669572 | Lenvatinib and Pembrolizumab to Treat Patients With Anal or Rectum Cancer That Has Gotten… | Carcinoma, Squamous Cell | Recruiting | 2026-04-15 |
Diabetes (14) · Prostate Cancer (11) · Leukemia (10) · Breast Cancer (9) · Heart Disease (9) · Head & Neck Cancer (8) · Multiple Myeloma (7) · Type 1 Diabetes (7) · Anxiety (6) · Colorectal Cancer (6)